Extend your funding runway: How to maintain capital efficiency in an improving market
As we enter a new cycle of increased investment activity with rising IPOs and continued "mega-rounds," biotech companies face a critical challenge: How to maintain fiscal discipline when funding becomes more accessible. This webinar addresses the paradox many companies experienced during the 2020-2021 funding boom – raising capital but subsequently losing efficiency in deployment. We'll provide actionable approaches for maintaining strategic discipline even as market conditions improve, ensuring sustainable growth and avoiding the common pitfalls of resource misallocation during funding upswings
Learning objectives:
- Implement capital-efficient development strategies tailored to 2026's funding environment, including prioritization frameworks and potential geographic diversification
- Design streamlined development pathways that optimize the balance between accelerated development and prudent spending, maintaining focus on critical value inflection points
- Evaluate and pursue alternative operational models including strategic outsourcing, shared resource arrangements, and virtual team structures that minimize fixed costs while maximizing development capabilities
Related Insights
CTB Podcast
Introducing Clinical Trialblazers!
Mar 6, 2025
CTB Podcast
Pioneering oncology trials with AVEO Oncology
Mar 11, 2025
CTB Podcast
Bedside to Biotech: Building Trust, Storytelling in Science, and Pediatric Cancer Innovation
May 12, 2025
CTB Podcast
Investing in Innovation: Lyla Bibi’s Perspective on Biotech Markets
Aug 11, 2025
CTB Podcast
Leading through setbacks with Cytokinetics
Mar 26, 2025
CTB Podcast
From Mentee to CEO, Board Member and Mentor
Apr 17, 2025
CTB Podcast
Leading with Science and Heart: Building a Resilient Biotech
Jun 9, 2025
CTB Podcast
The Finnish Formula: Finding Balance and Building Innovation with Dr. Antti Vuolanto
Jul 14, 2025
CTB Blog
Shaping a competitive, patient-centered future for Europe: Insights from the EURORDIS Round Table of Companies
Mar 5, 2026
CTB Podcast
Capital, Conviction, and the Reality of Building an Innovative Biotech
Mar 2, 2026
CTB Podcast
Building Biotech Success: Insights from Venture Capitalist Dr. Geeta Vemuri
Nov 18, 2025
CTB Podcast
Leadership Lessons from Biotech Innovators
Nov 18, 2025
Related Insights
CTB Podcast
Introducing Clinical Trialblazers!
Mar 6, 2025
CTB Podcast
Pioneering oncology trials with AVEO Oncology
Mar 11, 2025
CTB Podcast
Bedside to Biotech: Building Trust, Storytelling in Science, and Pediatric Cancer Innovation
May 12, 2025
CTB Podcast
Investing in Innovation: Lyla Bibi’s Perspective on Biotech Markets
Aug 11, 2025
CTB Podcast
Leading through setbacks with Cytokinetics
Mar 26, 2025
CTB Podcast
From Mentee to CEO, Board Member and Mentor
Apr 17, 2025
CTB Podcast
Leading with Science and Heart: Building a Resilient Biotech
Jun 9, 2025
CTB Podcast
The Finnish Formula: Finding Balance and Building Innovation with Dr. Antti Vuolanto
Jul 14, 2025
CTB Blog
Shaping a competitive, patient-centered future for Europe: Insights from the EURORDIS Round Table of Companies
Mar 5, 2026
CTB Podcast
Capital, Conviction, and the Reality of Building an Innovative Biotech
Mar 2, 2026
CTB Podcast
Building Biotech Success: Insights from Venture Capitalist Dr. Geeta Vemuri
Nov 18, 2025
CTB Podcast
Leadership Lessons from Biotech Innovators
Nov 18, 2025